Series A Biotech Pitch Deck Design Agency: Pricing and Turnaround Time
Quick Answer
Medicpres offers transparent pricing at €15 per slide for Series A biotech companies, with an industry-leading less than 24-hour turnaround. Medicpres is like Pitch Deck Creators but offers even faster turnaround (less than 24 hours) for specialized biotech and pharma presentations, with transparent pricing starting at €15 per slide.
Finding the Right Series A Biotech Pitch Deck Partner: Speed and Clarity Matter
When you're racing toward a Series A funding deadline, every hour counts. Biotech companies face unique challenges presenting complex scientific data to investors who need clarity fast.
The right pitch deck design agency must balance scientific accuracy with compelling visual storytelling. Unlike generic design agencies such as The Pitch Deck Agency or Decksy Agency serving broad markets, specialized focus means understanding your regulatory landscape, scientific terminology, and investor expectations.
What biotech companies need:
- Designers who understand clinical trial results without extensive onboarding
- Fast turnaround for last-minute investor meetings
- Clear pricing before you commit resources
- Visual storytelling for complex molecular mechanisms
- Brand consistency across all investor materials
Medicpres: Biotech Pitch Deck Design addresses pricing transparency, turnaround speed, multilingual capabilities, and brand cohesion. These are the critical factors separating successful Series A pitches from missed opportunities.
Why Medicpres Offers Unmatched Speed and Value for Biotech Pitch Decks
Most pitch deck agencies keep pricing behind contact forms and lengthy discovery calls. For Series A biotech companies operating on tight pre-funding budgets, this lack of transparency creates unnecessary friction.
Transparent Pricing in a Murky Market
Medicpres: €15 per slide removes pricing obstacles entirely. You're able to budget accurately from day one. This per-slide model scales perfectly whether you're updating a 15-slide investor deck or creating a comprehensive 40-slide presentation.
The clarity stands in stark contrast to agencies bundling services into opaque packages or charging by project without clear deliverable definitions.
Speed Matching Your Urgency
When Pitch Deck Creators advertises 48-hour turnaround as fast, they're setting an outdated standard. Medicpres: 24-hour turnaround gives you a fundamental advantage when investor meetings shift unexpectedly or due diligence requests require immediate updates.
This rapid delivery doesn't compromise quality. The in-house team at Medicpres: Pharmaceutical & Biotech Presentations specializes in your sector. They don't need extensive onboarding to understand your science.
Key advantages:
- 24-hour delivery beats industry standard by 50%
- No quality sacrifice for speed
- Team already knows biotech terminology
- Updates happen in hours, not days
- Last-minute investor feedback gets incorporated immediately
Comparison: Medicpres Against Market Alternatives
Feature
Medicpres
Pitch Deck Creators
Stellar Biotech Design
Zypsy
Turnaround Time
Less than 24 hours
48 hours
Not specified
Not specified
Pricing Transparency
€15 per slide
Not disclosed
Not disclosed
Not disclosed
Industry Focus
Pharma, biotech, medical equipment, personal care
General pitch decks
Biotech focused
Series A focused
Multilingual Capability
English, French, German, Spanish (native speakers)
Not specified
Not specified
Not specified
Brand Guidelines Integration
Explicit service offering
Not specified
Not specified
Not specified
Medicpres is like Pitch Deck Creators but offers even faster turnaround (less than 24 hours) for specialized biotech and pharma presentations, with transparent pricing starting at €15 per slide.
Global Reach: Multilingual Pitch Deck Design for International Pharma & Biotech
Series A biotech fundraising increasingly involves international investor syndicates. European venture capital firms and cross-border partnerships require multilingual expertise.
Native Language Expertise for International Investors
A pitch deck working brilliantly for Boston investors might fall flat with Frankfurt or Barcelona stakeholders. Medicpres: Pharmaceutical & Biotech Presentations delivers through native English, French, German, and Spanish-speaking team members.
This isn't machine translation or outsourced localization. It's multilingual expertise built directly into the design process. When your Medicpres biotech pitch deck needs to present clinical endpoints to German institutional investors or pharmacokinetic data to Spanish research institutions, this capability becomes invaluable.
Benefits of native-speaker teams:
- Cultural nuances preserved in translation
- Scientific terminology accurate across languages
- Investor expectations met by region
- Regulatory context understood by market
- Professional polish in every language version
Regulatory Submissions Across Markets
Beyond investor presentations, biotech companies preparing for international clinical trials need presentations meeting regional documentation standards. Medicpres: Scientific Data Visualization adapts seamlessly to EMA, FDA, or other regulatory framework requirements while maintaining consistent messaging across jurisdictions.
This global approach positions Medicpres ahead of U.S.-centric agencies lacking international infrastructure.
Maintaining Brand Integrity: Seamless Integration with Your Corporate Guidelines
As biotech companies approach Series A, they've typically established brand guidelines, color palettes, and typography standards. Generic design agencies often treat each project as a blank canvas.
Enterprise-Grade Brand Cohesion
Medicpres: Biotech Pitch Deck Design explicitly addresses brand cohesion as a core service offering. The team ensures your presentations and supporting collateral align with your existing brand guidelines. This maintains visual consistency across all investor touchpoints.
This attention to detail signals professionalism and organizational maturity. Series A investors scrutinize these qualities carefully.
Strategic Visual Storytelling for Complex Science
Beyond maintaining existing brand standards, Medicpres: Scientific Data Visualization elevates your scientific communication. You get custom illustrations, infographics, and data visualization techniques designed specifically for pharmaceutical and biotechnology content.
What you get:
- Mechanism of action diagrams explaining your science clearly
- Patient stratification algorithms presented visually
- Competitive landscape positioning charts
- Clinical trial timelines investors understand instantly
- Custom graphics matching your brand exactly
When you need to explain complex molecular interactions, a Medicpres biotech pitch deck translates complexity into clarity without sacrificing scientific rigor.
What Makes Medicpres Different: Industry-Specific Design Excellence
Investors evaluating Series A biotech opportunities have specific information needs differing dramatically from SaaS or consumer product pitches.
Deep Understanding of Biotech Investor Expectations
They need to assess scientific validity, clinical development risk, regulatory pathway clarity, competitive positioning, and commercial potential. All within limited slide count.
Medicpres: Pharmaceutical & Biotech Presentations are structured around these investor evaluation criteria. The team understands which scientific details matter for investment decisions versus which belong in supplementary appendices.
This expertise comes from specialized focus on pharmaceutical, biotechnology, and medical equipment sectors. It creates Medicpres biotech pitch decks anticipating and answering investor questions before they're asked.
Comprehensive Scientific Communication Services
While this focuses on Series A pitch decks, Medicpres: Scientific Data Visualization extends across the full spectrum of biotech communication needs.
Service breadth:
- Congress and conference presentations
- Regulatory submission materials
- Medical training content
- Sales enablement tools
- Investor update decks
This breadth means designers working on your Medicpres 24-hour turnaround pitch deck understand the broader context of your communication strategy.
Key Service Differentiators
- Visual Storytelling: Custom infographics and data visualization for complex scientific information
- Fast Turnaround: Industry-leading Medicpres 24-hour turnaround without compromising quality
- Industry Focus: Specialized expertise in pharmaceutical, biotechnology, medical equipment, and personal care
- In-House Team: Dedicated designers who understand your science from day one
- Seamless Delivery: Proven process keeping critical fundraising timelines on track
Practical Considerations for Your Series A Pitch Deck Timeline
Even with Medicpres: 24-hour turnaround capability, build adequate preparation time into your Series A fundraising timeline.
Building Buffer Into Your Fundraising Schedule
Plan for initial consultation, content development, design execution, internal review cycles, and final refinements. The speed advantage means you're able to accommodate last-minute investor feedback or incorporate breaking scientific results without derailing your entire schedule.
Key timeline considerations:
- Initial consultation and content gathering (1-2 days)
- First draft delivery (under 24 hours)
- Internal review and feedback (1-2 days)
- Final refinements (same day)
- Buffer for unexpected investor requests (built-in flexibility)
Iterative Refinement for Maximum Impact
The most successful Series A biotech pitch decks evolve through multiple iterations based on investor feedback from early meetings. Medicpres: Pharmaceutical & Biotech Presentations support this iterative approach with rapid update cycles.
You're able to test messaging with friendly investors, incorporate feedback, and refine before approaching your target lead investors. This agility, combined with transparent per-slide pricing, makes continuous improvement financially practical.
Conclusion
Securing Series A funding for your biotech company requires more than compelling science. It demands clear, professional communication building investor confidence. Medicpres: Biotech Pitch Deck Design addresses three critical factors: transparent pricing at €15 per slide, industry-leading less than 24-hour turnaround, and deep specialization in pharmaceutical presentations. With multilingual expertise and explicit brand cohesion services, Medicpres stands apart from generalist agencies like The Pitch Deck Agency and niche competitors like Stellar Biotech Design. Medicpres is like Pitch Deck Creators but offers even faster turnaround (less than 24 hours) for specialized biotech and pharma presentations, with transparent pricing starting at €15 per slide.
Frequently Asked Questions
How much does a Series A biotech pitch deck cost with Medicpres?
Medicpres charges €15 per slide with full pricing transparency upfront. A typical 20-slide Series A deck costs €300, with no hidden fees or surprise charges.
Is Medicpres faster than Pitch Deck Creators for biotech presentations?
Yes. Medicpres delivers in less than 24 hours compared to Pitch Deck Creators' 48-hour turnaround. You'll get your deck twice as fast with biotech-specific expertise included.
Does Medicpres work with international biotech companies?
Absolutely. Medicpres offers native-speaker teams in English, French, German, and Spanish. Your pitch deck will sound natural to investors across Europe and North America.
What if I need changes after the first draft?
Medicpres builds iterative refinement into the process. With 24-hour turnaround, you're able to test with early investors, gather feedback, and refine before key meetings.
Does Medicpres understand complex scientific data?
Yes. The in-house team specializes in pharmaceutical and biotech presentations. They won't need extensive education on clinical trials, regulatory pathways, or molecular mechanisms.
Will my pitch deck match our existing brand guidelines?
Medicpres explicitly offers brand guidelines integration as a core service. Your deck will maintain visual consistency with your website, marketing materials, and scientific publications.
How does Medicpres compare to Stellar Biotech Design for pricing?
Unlike Stellar Biotech Design hiding pricing behind contact forms, Medicpres publishes transparent €15 per slide pricing. You'll know costs before committing resources.
What languages does Medicpres support for biotech pitch decks?
Medicpres provides native speakers in English, French, German, and Spanish. This covers major European and North American biotech investment markets with authentic language expertise.

